Sterigenics International, Inc. Advances Plans with EO Sterilization Complex in Costa Rica
Oak Brook, IL - June 22, 2011: Sterigenics International, Inc., the global leader in contract sterilization and ionization services to the medical device, pharmaceutical, food safety and advanced applications industries, has entered into a build/lease agreement with ProPark and will commence construction of its newest state-of-the-art, ethylene oxide sterilization facility near San José, Costa Rica.
"With the completion of the sale of Sterigenics to GTCR, a leading private equity firm, we are now looking forward to expanding our operational footprint to our customers. We have agreements with two major medical device companies that will provide the initial base load of business for the facility. EO chambers and emission control equipment have been ordered and we have entered into a build/lease agreement with Propark in Costa Rica," said Patrick J. Hughes, Vice President of Sales and Marketing for Sterigenics in the Americas.
"Costa Rica is an attractive manufacturing and distribution base for medical device manufacturers. This project is a great opportunity to execute on our strategy of expanding our global network of facilities and technologies to service our customer base. We are very appreciative of the support from the Costa Rican government and the Costa Rican Investment Promotional Agency (CINDE). We believe that as our customer base continues to grow in Costa Rica, additional investments will follow," said David E. Meyer, President and CEO of Sterigenics.
Sterigenics will begin construction in the next few months, and expects the new facility to be fully operational in June of 2012.
About Sterigenics International
Sterigenics International Inc. is a portfolio company of GTCR, a Chicago-based private equity firm. Headquartered in the Chicago suburb of Oak Brook, IL, Sterigenics International, Inc. is the only company in the world to offer technology in all leading sterilization modalities, including: gamma, ethylene oxide, electron beam and X-ray. The company has more than 1,300 employees and operates 38 service centers in North America, Europe and Asia.
About GTCR
Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Financial Services & Technology, Healthcare and Information Services & Technology industries. The Chicago-based firm pioneered the "Leaders Strategy" - finding and partnering with world-class leaders as the critical first step in identifying, acquiring and building market-leading companies through acquisitions and organic growth. Since its inception, GTCR has invested more than $8.5 billion in over 200 companies. For more information, please visit www.gtcr.com.
